Manipulation of cytokine production profiles as a therapeutic approach for immunologic pregnancy loss

Indian Journal of Biochemistry and Biophysics

Volumn 45, Issue 4, 2008, Pages 229-236

  Raghupathy, Raj ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Cytokines; Pre term delivery; Recurrent miscarriage

Indexed keywords

AUTACOID; CYTOKINE; DYDROGESTERONE; PROGESTERONE;

BIOSYNTHESIS; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY; REVIEW; SPONTANEOUS ABORTION; TH1 CELL; TH2 CELL;

ABORTION, SPONTANEOUS; CYTOKINES; DYDROGESTERONE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; PROGESTERONE; TH1 CELLS; TH2 CELLS;

EID: 84924245506     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Cramer D W & Wise L A (2000) The epidemiology of recurrent pregnancy loss. Seminars Reprod Med 18, 331-339
2. lams J D & Creasy R K (2004) In: Maternal-Fetal Medicine (Creasy R K, lams J D, Resnik R, eds), pp 623-661, Saunders, Philadelphia
3. Hamilton B E, Martin J A, Ventura S J, Sutton P D & Menacker F (2005) Births, preliminary data for 2004 National Vital Statistics Reports (US Department of Health and Human Services) 54, pp 1-17
4. Cunningham F G, Leveno K J, Gilstrap LC, Hauth J C, Wenstrom K D & Bloom S L (2005) Williams Obstetrics, McGraw-Hill Education, New York
5. Mosmann T R & Sad S (1996) The expanding universe of T-cell subsets. Immunol Today 17, 138-146
6. Coffman R L & Romagnani S (eds) (1999) Redirecting Th1 and Th2 subsets, Springer-Verlag Berlin
7. Wegmann T G, Lin H, Guilbert L & Mosmann T R (1993) Bidirectional cytokine interactions in the maternal-fetal relationship, is successful pregnancy a Th2 phenomenon? Immunol Today 14, 353-356
8. Raghupathy R (2001) Pregnancy, success and failure within the Thl/Th2/Th3 paradigm. Seminars Immunol 13, 219-227
9. Chaouat G, Menu E, Clark D A, Dy M, Minkowski M & Wegmann T G (1990) Control of fetal survival in CBAxDBA/2 mice by lymphokine therapy. J Reprod Fertil 89, 447-457
10. Haimovici F, Hill J A & Anderson D J (1991) The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol Reprod 44, 69-76
11. Yui J, Garcia-Lloret M, Wegmann T G & Guilbert L (1994) Cytotoxicity of tumor necrosis factor-α (TNF-α) and gamma-interferon (IFN-γ) against primary human placental trophoblasts. Placenta 15, 819-828
12. Tangri S, Wegmann T G, Lin H & Raghupathy R (1994) Maternal anti-placental reactivity in natural, immunologically-mediated spontaneous fetal resorptions. J Immunol 152, 4903-4911
13. Polgar K & Hill J A (2002) Identification of the white blood cell populations responsible for Th1 immunity to trophoblast and the timing of the response in women with recurrent pregnancy loss. Gynecologic Obstetric Investig 53(1), 59-64
14. Makhseed M, Raghupathy R, Azizieh F, Al-Azemi M M K, Hassan N A & Bandar A (1999) Mitogen-induced cytokine responses of maternal peripheral blood lymphocytes indicate a differential Th-type bias in normal pregnancy and pregnancy failure. Am J Reprod Immunol 42, 273-281
15. Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M & Farhat R (2000) Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 15, 713-718
16. Raghupathy R, Makhseed M, Azizieh F, Hassan N, AlAzemi M & Al-Shamali E (1999) Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 196, 122-130
17. Marzi M, Vigano A, Trabattoni D, Villa M L, Salvaggio A, Clerici F & Clerici M (1996) Characterization of type I and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 106, 127-133
18. Piccinni M-P, Beloni L, Livi C, Maggi E, Scarselli G & Romagnani S (1998) Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nature (Med) 4, 1020-1024
19. Jenkins C, Roberts J, Wilson R, MacLean M A, Shilito J & Walker J J (2000) Evidence of a Th1 type response associated with recurrent miscarriage. Fertil Steril 73, 1206-1208
20. Lim K J H, Odukoya O A, Ajjan R A, Li T-C, Weetman A P & Cooke I D (2000) The role of T-helper cytokines in human reproduction. Fertil Steril 73, 136-142
21. Baines M G, Duelos A J, Antecka E & Haddad E K (1997) Decidual infiltration and activation of macrophages leads to early embryo loss. Am J Reprod Immunol 37, 471-477
22. Hill J A & Choi B C (2000) Immunodystrophisni, evidence for a novel alloimmune hypothesis for recurrent pregnancy loss involving ThI-type immunity to trophoblast. Sem Reprod Med 18, 401-405
23. Loke Y W & King A (2000) Decidual natural-killer-cell interaction with trophoblast, cytolysis or cytokine production? Biochem Soc Trans 28, 196-198
24. Haddad E K, Duelos A J, Lapp W S & Baines M G (1997) Early embryo loss is associated with the prior expression of macrophage activation markers in the deciduas. J Immunol 158, 4886-4892
25. Knackstedt M, Ding J W, Arck P C, Hertwig K, Coulam C B, August C, Lea R, Dudenhausen J W, Gorczynski R M, Levy G A & Clark D A (2001) Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. Am J Reprod Immunol 46, 196-210
26. Keelan J A, Blumenstein M, Helliwell R J A, Sato T A, Marvin K W & Mitchell M D (2003) Cytokines, prostaglandins and parturition, A review. Placenta 24, Suppl A17, S33-S46
27. Keelan J A, Marvin K W, Sato T A, Coleman M, McCowan L M & Mitchell M D (1999) Cytokine abundance in placental tissues, evidence of inflammatory activation in gestational membranes with term and pre-term parturition. Am J Obstet Gynecol 181, 1530-1536
28. Inglis S R, Jeremias J, Kuno K, Lescale K, Peeper Q & Chervenak F A (1994) Detection of tumor necrosis factor-α, interleukin-6 and fetal fibronectin in the lower genital tract during pregnancy, Relation to outcome. Am J Obstet Gynecol 171, 5-10
29. Romero R, Espinoza J, Goncalves L F, Kusanovic J P, Friel L & Hassan S (2007) The role of inflammation and infection in pre-term birth. Seminars Reprod Med 25, 21-39
30. Dudley D J (1997) Pre-term labor, an intra-uterine inflammatory response syndrome? J Reprod Immunol 36, 93-109
31. Arntzen K J, Kjolesdal A M, Halgunset J, Vatten L & Austgulen R (1998) TNF, IL-I, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinatal Med 26, 17-26
32. Makhseed M, Raghupathy R, El-Shazly S, Azizieh F & AI-Hanni J A (2003) Pro-inflammatory maternal cytokine profile in pre-term delivery. Am J Reprod Immunol 49, 1-12
33. Stites D P, Bugbee S & Siiteri P K (1983) Differential actions of progesterone and Cortisol on lymphocyte and monocyte interaction during lymphocyte activation relevance to immunosuppression in pregnancy. J Reprod Immunol 5, 215-228
34. Piccinni M P, Giudizi M G, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annunziato F & Li vi C (1995) Progesterone favors the development of human t helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established T cell clones. J Immunol 155, 128-133
35. Raghupathy R, Al Mutawa E, Makhseed M & Szekcres-Bartho J (2005) Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. Brit J Obstet Gynecol 112, 1096-1101
36. Raghupathy R, Al Mutawa E, Makhseed M & Azizieh F (2007) Dydrogesterone redirects cytokine production profiles in lymphocytes from women with pre-term delivery. Am J Reprod Immunol, (In Press)
37. Doggrell S A (2003) Recurrent hope for the treatment of preterm delivery. Exp Opin Pharmacother 4, 2362-2366
38. Meis P J, Klebanoff M, Thiom E, Dombrowski M P & Sibai B (2003) Prevention of recurrent pre-term delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348, 2379-85
39. Meis P J, Klebanoff M, Dombrowski M P, Sibai B M, Leindecker S & Moawad A M (2005) Does progesterone treatment influence risk factors for recurrent pre-term delivery? Obstet Gynecol 106, 557-561
40. Spong C Y, Meis P J, Thorn E A, Sibai B & Dombrowski M P (2005) Progesterone for prevention of recurrent pre-term birth, Impact of gestational age at previous delivery. Am J Obstet Gynecol 193, 1127-1131
41. Sanchez-Ramos L, Kaunitz A M & Delke I (2005) Progestational agents to prevent pre-term birth, a meta-analysis of randomized controlled trials. Obstet Gynecol 105, 273-279
42. Thornton S & Gillespie J I (1992) Biochemistry of uterine contractions. Contemporary Reviews. Obstet Gynaecol 4, 121-126
43. Egarter C A & Hussein P (1992) Biochemistry of myomctria contractility. Clin Obstet Gynecol 6, 755-69
44. Fuchs A R & Fuchs R (1984) Endocrinology of human parturition: a review. Br J Obstet Gynecol 91, 948-967
45. Choi B C, Polgar K, Xiao L & Hill J A (2000) Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 15 (Suppl 1), 46-59
46. Stanczyk F Z (1999) Pharmacokinetics of progesterone administered by the oral and parenteral routes. J Reprod Med 44, 141-147
47. Simon J A, Robinson D E & Andrews M C (1993) The absorption of oral micronised progesterone, the effect of food, dose proportionality and comparison with intramuscular progesterone. Fertil Steril 60, 26-33
48. Maxson W S & Hargrove J T (1985) Bioavailability of oral micronized progesterone. Fertil Steril 44, 622-626